04.29.23
Here's your weekly recap—the most viewed news stories on our site for the week ended April 29, 2023.
Kimberly-Clark's Poise brand has launched Poise 7 Drop pads for bladder leaks, designed to give women the best protection (vs. national brand daytime pads) and helps them avoid leaks with up to 100% clean, dry, and fresh protection. The curved-shaped pad with contour helps prevent bunching, and women can remain comfortable throughout the day.
In other news, Essity has decided to initiate a strategic review of the company’s ownership of the Asian hygiene company Vinda International Holdings Ltd (Vinda) and the Consumer Tissue Private Label Europe business with the aim of reducing Consumer Tissue’s share of the company’s total sales. Essity continuously evaluates the product portfolios within the company’s three business areas, Health & Medical, Consumer Goods and Professional Hygiene, to achieve increased long-term value creation. In line with this, Essity is initiating a strategic review of the company’s ownership of Vinda and the Consumer Tissue Private Label Europe business. The strategic review includes exploring different options and may result in divestments, although no such decisions have yet been taken.
Here are our top 3 most viewed stories from the past week:
1. Poise Launches 7 Drop Pads
2. Essity Initiates Strategic Review of Vinda and Consumer Tissue Private Label Europe Business
3. Predo to Add Two Hygiene Converting Lines
Kimberly-Clark's Poise brand has launched Poise 7 Drop pads for bladder leaks, designed to give women the best protection (vs. national brand daytime pads) and helps them avoid leaks with up to 100% clean, dry, and fresh protection. The curved-shaped pad with contour helps prevent bunching, and women can remain comfortable throughout the day.
In other news, Essity has decided to initiate a strategic review of the company’s ownership of the Asian hygiene company Vinda International Holdings Ltd (Vinda) and the Consumer Tissue Private Label Europe business with the aim of reducing Consumer Tissue’s share of the company’s total sales. Essity continuously evaluates the product portfolios within the company’s three business areas, Health & Medical, Consumer Goods and Professional Hygiene, to achieve increased long-term value creation. In line with this, Essity is initiating a strategic review of the company’s ownership of Vinda and the Consumer Tissue Private Label Europe business. The strategic review includes exploring different options and may result in divestments, although no such decisions have yet been taken.
Here are our top 3 most viewed stories from the past week:
1. Poise Launches 7 Drop Pads
2. Essity Initiates Strategic Review of Vinda and Consumer Tissue Private Label Europe Business
3. Predo to Add Two Hygiene Converting Lines